Weishan Huang

Dr. Weishan Huang

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
DODavid L. Owen
David L. Owen
SMShawn A. Mahmud
Shawn A. Mahmud
LSLouisa E. Sjaastad
Louisa E. Sjaastad
JWJason B. Williams
Jason B. Williams
JSJustin A. Spanier
Justin A. Spanier
MFMichael A. Farrar
Michael A. Farrar

19 March 2022 in Viruses
Verified
Journal Article
Open access
PDF file
NMNicholas Magazine
Nicholas Magazine
TZTianyi Zhang
Tianyi Zhang
YWYingying Wu
Yingying Wu
MMMichael C McGee
Michael C McGee
GVGianluca Veggiani
Gianluca Veggiani
WHWeishan Huang
Weishan Huang
The SARS-CoV-2 spike protein mediates target recognition, cellular entry, and ultimately the viral infection that leads to various levels of COVID-19 severities. Positive evolutionary selection of mutations within the spike protein has led to the genesis of new SARS-CoV-2 variants with greatly enhanced overall fitness. Given the trend of variants with increased fitness arising from spike protein alterations, it is critical that the scientific community understand the mechanisms by which these mutations alter viral functions. As of March 2022, five SARS-CoV-2 strains were labeled “variants of concern” by the World Health Organization: the Alpha, Beta, Gamma, Delta, and Omicron variants. This review summarizes the potential mechanisms by which the common mutations on the spike protein that occur within these strains enhance the overall fitness of their respective variants. In addressing these mutations within the context of the SARS-CoV-2 spike protein structure, spike/receptor binding interface, spike/antibody binding, and virus neutralization, we summarize the general paradigms that can be used to estimate the effects of future mutations along SARS-CoV-2 evolution.

28 February 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JCJi Cao
Ji Cao
LSLei Sun
Lei Sun
PAPornpun Aramsangtienchai
Pornpun Aramsangtienchai
NSNicole A. Spiegelman
Nicole A. Spiegelman
XZXiaoyu Zhang
Xiaoyu Zhang
HLHening Lin
Hening Lin
Significance: HDAC11 is the only class IV member of the histone deacetylase (HDAC) family, and very little is known about its biological function. The work here reveals its efficient and physiologically relevant activity. The regulation of SHMT2 and interferon signaling expands the known biological function of protein lysine fatty acylation, which has only recently started to be appreciated. Furthermore, a compelling molecular mechanism is proposed to connect HDAC11 to immune response. The finding opens exciting opportunities to develop HDAC11-specific inhibitors to treat human diseases that would benefit from increased type I interferon signaling, such as viral infection, multiple sclerosis, and cancer.

1 March 2020 in Pharmacology & Therapeutics
Verified
Journal Article
Open access
NNNatalie F. Nidetz
Natalie F. Nidetz
MMMichael C. McGee
Michael C. McGee
LTLong Ping Victor Tse
Long Ping Victor Tse
CLChengwen Li
Chengwen Li
LCLe Cong
Le Cong
WHWeishan Huang
Weishan Huang
Adeno-associated viral (AAV) vectors have emerged as the leading gene delivery platform for gene therapy and vaccination. Three AAV-based gene therapy drugs, Glybera, LUXTURNA, and ZOLGENSMA were approved between 2012 and 2019 by the European Medicines Agency and the United States Food and Drug Administration as treatments for genetic diseases hereditary lipoprotein lipase deficiency (LPLD), inherited retinal disease (IRD), and spinal muscular atrophy (SMA), respectively. Despite these therapeutic successes, clinical trials have demonstrated that host anti-viral immune responses can prevent the long-term gene expression of AAV vector-encoded genes. Therefore, it is critical that we understand the complex relationship between AAV vectors and the host immune response. This knowledge could allow for the rational design of optimized gene transfer vectors capable of either subverting host immune responses in the context of gene therapy applications, or stimulating desirable immune responses that generate protective immunity in vaccine applications to AAV vector-encoded antigens. This review provides an overview of our current understanding of the AAV-induced immune response and discusses potential strategies by which these responses can be manipulated to improve AAV vector-mediated gene transfer.

5 August 2020 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SSSabrina Solouki
Sabrina Solouki
WHWeishan Huang
Weishan Huang
JEJessica Elmore
Jessica Elmore
CLCandice Limper
Candice Limper
FHFei Huang
Fei Huang
AAAvery August
Avery August
CD8+ T cells play a critical role in adaptive immunity, differentiating into CD8+ memory T cells that form the basis of protective cellular immunity. Vaccine efficacy is attributed to long-term protective immunity, and understanding the parameters that regulate development of CD8+ T cells is critical to the design of T cell–mediated vaccines. We show in this study using mouse models that two distinct parameters, TCR signal strength (regulated by the tyrosine kinase ITK) and Ag affinity, play important but separate roles in modulating the development of memory CD8+ T cells. Unexpectedly, our data reveal that reducing TCR signal strength along with reducing Ag affinity for the TCR leads to enhanced and accelerated development of CD8+ memory T cells. Additionally, TCR signal strength is able to regulate CD8+ T cell effector cytokine R production independent of TCR Ag affinity. Analysis of RNA-sequencing data reveals that genes for inflammatory cytokines/cytokine receptors are significantly altered upon changes in Ag affinity and TCR signal strength. Furthermore, our findings show that the inflammatory milieu is critical in regulating this TCR signal strength–mediated increase in memory development, as both CpG oligonucleotide treatment or cotransfer of wild-type and Itk−/− T cells eliminates the observed increase in memory cell formation. These findings suggest that TCR signal strength and Ag affinity independently contribute to CD8+ memory T cell development, which is modulated by inflammation, and suggest that manipulating TCR signal strength along with Ag affinity, may be used to tune the development of CD8+ memory T cells during vaccine development.

18 December 2014 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
WHWeishan Huang
Weishan Huang
AAAvery August
Avery August
T cell development, differentiation, and maintenance are orchestrated by 2 key signaling axes: the antigen-specific TCR and cytokine-mediated signals. The TCR signals the recognition of self- and foreign antigens to control T cell homeostasis for immune tolerance and immunity, which is regulated by a variety of cytokines to determine T cell subset homeostasis and differentiation. TCR signaling can synergize with or antagonize cytokine-mediated signaling to fine tune T cell fate; however, the latter is less investigated. Murine models with attenuated TCR signaling strength have revealed that TCR signaling can function as regulatory feedback machinery for T cell homeostasis and differentiation in differential cytokine milieus, such as IL-2-mediated Treg development; IL-7-mediated, nai¨ve CD8+ T cell homeostasis; and IL-4-induced innate memory CD8+ T cell development. In this review, we discuss the symphonic cross-talk between TCR and cytokine-mediated responses that differentially control T cell behavior, with a focus on the negative tuning by TCR activation on the cytokine effects.